TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
GNR-060 (tenecteplase biosimilar) - Generium
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction (clinicaltrials.gov) - Sep 22, 2026 - P3 | N=244 | Completed | Sponsor: AO GENERIUM | Recruiting ➔ Completed 
Trial completion • Cardiovascular • Myocardial Infarction
http://clinicaltrials.gov/ct2/show/NCT05601999
 
Sep 22, 2026
 
Prev Next